Evidence map›Paper›PMID 35181549›Full record

ArticleTranslational research : the journal of laboratory and clinical medicine2022

A cortactin CTTN coding SNP contributes to lung vascular permeability and inflammatory disease severity in African descent subjects.

Patrick Belvitch, Nancy Casanova, Xiaoguang Sun, Sara M Camp, Saad Sammani, Mary E Brown, Joseph Mascarhenas, Heather Lynn, Djanybek Adyshev, Jessica Siegler and 14 more

Open access · greenAbstract read
In one paragraph

Article in Translational research : the journal of laboratory and clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Lung Lymphatics in Edema, Inflammation, and Thrombosis.Arteriosclerosis, thrombosis, and vascular biology · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Cortactin in Lung Cell Function and Disease.International journal of molecular sciences · 2022
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 1 country.

Patrick BelvitchDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Nancy CasanovaDepartment of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Xiaoguang SunDepartment of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Sara M CampDepartment of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Saad SammaniDepartment of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Mary E BrownUniversity of Minnesota, Minneapolis, Minnesota.
Joseph MascarhenasDepartment of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Heather LynnDepartment of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Djanybek AdyshevDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Jessica SieglerDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Ankit DesaiDepartment of Medicine, Indiana University, Indianapolis, Indiana.
Laleh Seyed-SaadatDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Alicia RizzoDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Christian BimeDepartment of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Gajendra S ShekhawatDepartment of Materials Science and Engineering, Northwestern University, Evanston, Illinois.
Vinayak P DravidDepartment of Materials Science and Engineering, Northwestern University, Evanston, Illinois.
John P ReillyDivision of Pulmonary, Allergy, and Critical Care Medicine and Lung Biology Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Tiffanie K JonesDivision of Pulmonary, Allergy, and Critical Care Medicine and Lung Biology Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Rui FengDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Eleftheria LetsiouDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois.
Nuala J MeyerDivision of Pulmonary, Allergy, and Critical Care Medicine and Lung Biology Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Nathan EllisDepartment of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Joe G N GarciaDepartment of Medicine, University of Arizona Health Sciences, Tucson, Arizona.
Steven M DudekDivision of Pulmonary, Critical Care, Sleep and Allergy, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois. Electronic address: sdudek@uic.edu.
University of Arizona · USUniversity of Illinois Chicago · USUniversity of Pennsylvania · USNorthwestern University · USIndiana University – Purdue University Indianapolis · USUniversity of Minnesota System · US

Funding

Structure-Function Analysis of nmMLCK in EC Barrier ResponsesP01HL126609 · NHLBI · UNIVERSITY OF FLORIDA · PI STEVEN M DUDEK · 2016 to 2026
$24.4M
Targeting Angiopoietin-2 in ARDSR01HL137006 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MEYER, NUALA JENNINGS · 2017 to 2021
$2.5M
Pathogenic Role of IL-18 in Sickle Cell Cardiomyopathy and Inducible Ventricular TachycardiaR01HL136603 · NHLBI · UNIVERSITY OF ARIZONA · PI DESAI, ANKIT A · 2017 to 2021
$2.4M
Reconsidering the IL-1 axis in sepsis-associated ARDSR01HL137915 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI MEYER, NUALA JENNINGS · 2017 to 2020
$2.1M
Cortactin in Regulation of Pulmonary Vascular PermeabilityR01HL088144 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEK, STEVEN M · 2007 to 2011
$1.9M
Group V Phospholipase A2 Mediates Acute Lung InjuryR01HL133059 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEK, STEVEN M · 2017 to 2020
$1.6M
Protein Regulation and Cytoskeletal Dynamics of Pulmonary Endothelial Barrier FunctionK08HL135318 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BELVITCH, PATRICK · 2017 to 2021
$975k
SELPLG as a candidate gene in Acute Respiratory Distress SyndromeK08HL141623 · NHLBI · UNIVERSITY OF ARIZONA · PI BIME, CHRISTIAN · 2018 to 2022
$863k
Cortactin in Regulation of Pulmonary Vascular PermeabilityR56HL088144 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DUDEK, STEVEN M · 2015 to 2015
$422k
Functional Characterization of ALI-Associated MYLK SNPsF30HL121982 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RIZZO, ALICIA N · 2014 to 2016
$136k
NHLBI NIH HHS F30 HL121982NHLBI NIH HHS K08 HL135318NHLBI NIH HHS K08 HL141623NHLBI NIH HHS P01 HL126609NHLBI NIH HHS R01 HL088144NHLBI NIH HHS R01 HL133059NHLBI NIH HHS R01 HL136603NHLBI NIH HHS R01 HL137006NHLBI NIH HHS R01 HL137915NHLBI NIH HHS R56 HL088144
6 · The paper itself

Abstract

The cortactin gene (CTTN), encoding an actin-binding protein critically involved in cytoskeletal dynamics and endothelial cell (EC) barrier integrity, contains single nucleotide polymorphisms (SNPs) associated with severe asthma in Black patients. As loss of lung EC integrity is a major driver of mortality in the Acute Respiratory Distress Syndrome (ARDS), sepsis, and the acute chest syndrome (ACS), we speculated CTTN SNPs that alter EC barrier function will associate with clinical outcomes from these types of conditions in Black patients. In case-control studies, evaluation of a nonsynonymous CTTN coding SNP Ser484Asn (rs56162978, G/A) in a severe sepsis cohort (725 Black subjects) revealed significant association with increased risk of sepsis mortality. In a separate cohort of sickle cell disease (SCD) subjects with and without ACS (177 SCD Black subjects), significantly increased risk of ACS and increased ACS severity (need for mechanical ventilation) was observed in carriers of the A allele. Human lung EC expressing the cortactin S484N transgene exhibited: (i) delayed EC barrier recovery following thrombin-induced permeability; (ii) reduced levels of critical Tyr486 cortactin phosphorylation; (iii) inhibited binding to the cytoskeletal regulator, nmMLCK; and (iv) attenuated EC barrier-promoting lamellipodia dynamics and biophysical responses. ARDS-challenged Cttn+/- heterozygous mice exhibited increased lung vascular permeability (compared to wild-type mice) which was significantly attenuated by IV delivery of liposomes encargoed with CTTN WT transgene but not by CTTN S484N transgene. In summary, these studies suggest that the CTTN S484N coding SNP contributes to severity of inflammatory injury in Black patients, potentially via delayed vascular barrier restoration.

Indexed as

Respiratory Distress SyndromeSepsisAnimalsCapillary PermeabilityCortactinHumansLungMicePolymorphism, Single NucleotideSeverity of Illness IndexCortactinCTTN protein, human

Identifiers

PMID35181549
PMCPMC9119916
OpenAlexW4213344769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.